Mechanism of the inhibitory action of endogenous cholecystokinin and caerulein on pentagastrin--induced gastric secretion.
D000818:Animals; D001626:Bethanechol Compounds / Q000494:pharmacology; D002108:Ceruletide / Q000494:pharmacology; D002766:Cholecystokinin / Q000502:physiology*; D004285:Dogs; D005747:Gastric Fistula; D005750:Gastric Juice / Q000378:metabolism*; D005753:Gastric Mucosa / Q000187:drug effects; D005765:Gastrointestinal Agents / Q000494:pharmacology*; D007930:Leucine / Q000494:pharmacology; D010179:Pancreas / Q000187:drug effects; D010185:Pancreatic Fistula; D010189:Pancreatic Juice / Q000378:metabolism*; D010418:Pentagastrin / Q000037:antagonists & inhibitors*; D010455:Peptides / Q000494:pharmacology*; D013270:Stomach / Q000601:surgery; D014364:Tryptophan / Q000494:pharmacology
D001626:Bethanechol Compounds; D005765:Gastrointestinal Agents; D010455:Peptides; D002108:Ceruletide; D014364:Tryptophan; D002766:Cholecystokinin; D010418:Pentagastrin; D007930:Leucine